The global Cannabidiol (CBD) market has shown remarkable growth, driven by increased consumer awareness and regulatory changes. In 2023, the market size was valued at USD 7.6 billion and is expected to reach USD 36.6 billion by 2033, growing at a compound annual growth rate (CAGR) of 27% during forecast period.
Several factors contribute to this growth. The legalization of cannabis in various regions and the growing applications of CBD in health and wellness products have significantly increased the market demand. The therapeutic benefits of CBD, including relief of chronic pain, anxiety, and neurological conditions, are widely recognized, leading to increased acceptance and use in pharmaceutical, nutraceutical, and personal care products.
Despite promising prospects, the market faces challenges such as strict regulations and misconceptions about the psychoactive effects of CBD, especially in developing regions. These misconceptions hinder market penetration and consumer acceptance.
Recent developments in the CBD market include advances in extraction and processing technologies, which improve product purity and efficacy. Companies are also investing in research and development to explore new applications and improve existing products. The growing interest in non-intoxicating cannabis derivatives and the continued expansion of CBD-infused products in various sectors highlight the dynamic nature of this market.
key points
- The global cannabidiol (CBD) market has been reached. 7.6 billion dollars by 2022, it is expected to grow 36.6 billion dollars in 2032 with a 17.5% CAGR.
- The marijuana segment leads the market, driven by greater acceptability and legalization for various medical applications. Hemp-derived CBD is also growing rapidly.
- CBD oil dominates product types, with more 30% market share, due to its effectiveness in the management of chronic pain.
- Pharmaceuticals are the most lucrative segment as there are more of them 25% of the market, driven by the neuroprotective and analgesic properties of CBD.
- Online pharmacies have the largest market share a 25%benefiting from the convenience and global reach of online sales.
- Increasing demand for personal care products, increasing R&D and growing awareness of the health benefits of CBD are key drivers of the market.
- Misconceptions about CBD products, especially in developing economies, pose a challenge to market growth.
- Advances in manufacturing technology, increased public-private financing, and changing lifestyles present growth opportunities for market players.
- Significant trends include the growing demand for CBD-infused products and increased research into the potential health benefits of CBD.
- COVID-19 disrupted supply chains, but increased demand for CBD products, especially for health and wellness purposes.
- North America dominates the market with a 60% share, while Europe and Asia-Pacific show emerging demand.
- Key players in the CBD market include Medical Marijuana Inc., Isodiol International Inc., Aurora Cannabis Inc. and Elixinol Global.
Get a sample PDF report: https://market.us/report/cannabidiol-market/request-sample/
Key segments of the cannabidiol market
Based on the source
Based on the product
- oil
- concentrates
- isolated
- Other Products
Based on the application
- pharmaceuticals
- Food and Beverages
- Pet care
- cosmetics
- Application of others
Based on the distribution channel
- Online pharmacies
- Hospitals
- Retail stores
- drugstores
- Another distribution channel
Key regions
- North America (USA, Canada, Mexico)
- Western Europe (Germany, France, United Kingdom, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic, Rest of Western Europe)
- Eastern Europe (Russia, Poland, Czech Republic, Greece, rest of Eastern Europe)
- APAC (China, Japan, South Korea, India, Australia and New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Rest of APAC)
- Latin America (Brazil, Colombia, Chile, Argentina, Costa Rica, Rest of Latin America)
- Middle East and Africa (Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, Rest of MEA)
Buy directly: https://market.us/purchase-report/?report_id=32147
Analysis of key players
Medical Marijuana Inc. is a pioneering company in the cannabidiol (CBD) sector, dedicated to the development, sale and distribution of hemp oil containing natural cannabinoids. The company offers a variety of CBD products, including capsules, tinctures, vaporizers and hemp foods, for the pharmaceutical, nutraceutical and cosmeceutical industries. It operates under several brands and has a significant market presence in more than 40 countries, including the US, Mexico and Brazil. In 2020, the company reported revenue of $46.9 million, driven by its broad product portfolio and high market margins.
Cannoid LLC specializes in producing high quality full spectrum CBD oil derived from organic hemp. The company emphasizes rigorous testing and quality control to ensure its products meet strict standards. Cannoid LLC’s offerings include CBD tinctures, edibles, and topicals that are designed to support overall wellness. The company is known for its innovation in product development and its commitment to transparency and sustainability in the cannabidiol industry.
Isodiol International Inc. focuses on the manufacture and distribution of pharmaceutical grade CBD products. The company leverages advanced extraction techniques to produce highly pure CBD isolates and full-spectrum hemp extracts. Isodiol’s product range includes wellness supplements, skin care products and CBD-infused beverages. The company is also engaged in research and development to explore new therapeutic applications of cannabidiol, with the goal of expanding its impact in the health and wellness sector.
ENDOCA is a world leader in the production of organic CBD products. Founded with a mission to improve the quality of life through natural hemp-based solutions, ENDOCA offers a wide range of products, including CBD oils, capsules and skin care items. The company prides itself on using sustainable farming practices and rigorous testing protocols to ensure product purity and potency. ENDOCA’s commitment to education and advocacy for natural health solutions has established it as a trusted name in the cannabidiol market.
Folium Biosciences is a prominent player in the CBD industry, known for its large-scale production capabilities and high quality standards. The company specializes in the cultivation, extraction and formulation of CBD products derived from hemp. Folium Biosciences offers a diverse product portfolio, including bulk CBD oils, water-soluble CBD, and finished products such as tinctures and soft gels. Its emphasis on scientific research and compliance with regulatory standards have positioned it as a reliable supplier to the global cannabidiol market.
Key Players of Cannabidiol Market:
- Marijuana Medicine Inc.
- Cannonoid LLC
- Isodiol International Inc.
- ENDOCA
- Journal of Biosciences
- Aurora Cannabis Inc.
- Pharmahemp d.o.o
- Elixinol Global
- CV Sciences
- Medterra CBD
- Other key players
Scope of the Cannabidiol Market Report >> Market value (2023): $7.6 billion || Revenue forecast (2033): $36.6 billion || CAGR (2024-2033): 27% || Estimated base year: 2023 || Historical period: 2019-2022 || Forecast period: 2024-2033.
Find out more about the report: https://market.us/report/cannabidiol-market/#inquiry
About Market.US
Market.US is known for its comprehensive market research and analysis, providing customized and syndicated reports to a global clientele. Specializing in various sectors, they offer strategic insights and detailed market forecasts, helping companies make informed decisions. With a focus on innovation and accuracy, Market.US supports customers in more than 126 countries and maintains a strong repeat rate, underscoring its commitment to quality and customer satisfaction. Their team excels at providing exceptional research services, ensuring that no detail is overlooked in any target market.
Contact details
Market.us (provided by Prudour Pvt. Ltd.)
Contact number: +1 718 618 4351.
Email: inquiry@market.us
Blog: https://medicalmarketreport.com/
See more trend reports
Diabetes Treatment Devices Market to Reach $17.599 Billion by 2032
The preclinical CRO market will grow to $10.5 billion by 2032
The diagnostic imaging market size will reach $54.6 billion by 2032
Immune Thrombocytopenia Market to Grow $3.4 Billion by 2032
The home healthcare market is expected to reach USD 797.8 billion by 2033, showing a CAGR of 8.2%
